عکس

ChitoTech Hemostatic Products are made of natural cellulosic biopolymers. They cause rapid hemostasis in arterial, venous and capillary bleedings, useful in trauma, surgery, angiography catheters, dentistry, nasal and mouth bleeding, genital mutilation, traumatic skin incisions, hemodialysis and vascular problems. They save patients' life, decrease costs and hospital length of stay, blood transfusions, transmission of infection. They can be effective in conversion of hospitalization to outpatient treatment. 
Also, these products have been increasingly used in the field of inherited bleeding disorders including hemophilia, Glanzmann and Von Willebrand disease. 
ChitoTech Hemostatic Products are safe and effective for diabetic patients. 

 
Mechanism of Action:
ChitoTech hemostatic agent Absorbs blood plasma, therefore increases the concentration of clotting factors and platelets aggregation in the affected area. It then provides a matrix for platelet adhesion, accelerating the formation of the platelet plug.

 

 

According to biocompatibility tests, ChitoTech hemostatic products are biocompatible, with no evidence of cytotoxicity, inflammation, skin irritation, acute or chronic toxicity, genotoxicity or other complications related to incompatibility. 
 
References:
  
Mirzaei R, Mahjoobi B, Kordestani SS, NayebHabib F. ChitoHem hemostatic powder compared with electro-cautery anorectal surgery: A randomized controlled trial. 
   Darbemamieh G, Hashemi A, Kordestani SS, Karimian F, Najarian S. A novel haemostatic powder delivery device applicable in minimally invasive surgery. Journal of medical engineering & technology. 2014 Jan 1;38(1):32-6.
   Soheila S. Kordestani, Aref Rezaimanesh, Farzaneh NayebHabib. The use of oxidized regenerated cellulose (ChitoCell®) in open surgeries. 5th international conference on science and technology, France, 2016.
   Kordestani, Soheila S.,Noohi.F, Azarnik.H, Basiri.H, Hashemi.M.J., S.Abdi, A.Mohebi and NayebHabib.F. "A randomized controlled trial on the hemostasis of femoral artery using topical hemostatic agent." Clinical and Applied Thrombosis/Hemostasis 18, no.5 (2012):501-505.
   Eshghi P, Jenabzade A, Habibpanah B. A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies. Hematology. 2014 Sep 1;19(6):361-4.
  MH KM, Navi F, Rouhipour R, Jafari SM. Hemostatic tampon to reduce bleeding following tooth extraction. Iranian Red Crescent Medical Journal. 2012 Jun;2012(6, Jun):386-8. 

 


 

Address

Units 9 and 11,  Khaghani Building,No 83، Somayyeh street ,Tehran, Iran Postal code: 1571838318

Phone: +(98)21-88321517 - 19

Fax:  +(98) 21-88835224

Email: info@chitotech.com

 

Follow us on social media

 

t a a sfghghjfg